Barnett, D (2002) Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. National Institute for Clinical Excellence.
Barretto, EM, Kayo, M, Avrichir, BS
et al (2009) A preliminary controlled trial of cognitive behavioural therapy in clozapine resistant schizophrenia. Journal of Nervous and Mental Disease
Carrizo, E, Fernandez, V, Connell, L
et al (2009) Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14-week, double-blind, parallel group, placebo-controlled study. Schizophrenia Research
Cialdini, R (2008) Influence: Science and Practice (5th edn). Prentice Hall.
Cipriani, A, Boso, M, Barbui, C (2009) Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Cochrane Database of Systemic Reviews
Duckworth, K (1997) Lost time, found hope and sorrow: the search for self, connection, and purpose during ‘awakenings’ on the new antipsychotics. Harvard Review of Psychiatry
Frighi, V (2010) Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders. In Therapeutic Strategies in Schizophrenia (eds Mortimer, AM, McKenna, PJ) 1–20. Clinical Publishing.
Henderson, D, Kunkel, L, Nguyen, D
et al (2006) An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatrica Scandinavica
Kane, J, Honigfeld, G, Singer, J
et al (1988) Clozapine for the treatment-resistant schizophrenia. A double-blind comparison with chlorpromazine. Archives of General Psychiatry
Karunakaran, K, Tungaraza, T, Harborne, G (2007) Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
Journal of Psychopharmacology
Kelly, DL, Buchanan, RW (2010) The current status of clozapine in and beyond treatment-resistant schizophrenia. In Therapeutic Strategies in Schizophrenia (eds Mortimer, AM, McKenna, PJ) 157–72. Clinical Publishing.
Kim, SH, Jung, D, Ahn, YM
et al (2010) The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Journal of Psychopharmacology
McKenna, PJ (2010) Cognitive therapy for schizophrenia: does it work? In Therapeutic Strategies in Schizophrenia (eds Mortimer, AM, McKenna, PJ) 75–86. Clinical Publishing.
Metzer, HY, Bobo, WV, Lee, MA
et al (2010) A randomised trial comparing clozapine and typical neuroleptic drugs in non-treatment resistant schizophrenia. Psychiatry Research
Mortimer, AM (1997) A clozapine cohort: outcome and issues of concern. Human Psychopharmacology
Mortimer, AM (2007) Optimising drug treatments in rehabilitation practice. Progress in Neurology and Psychiatry
Mortimer, AM (2010) When monotherapy is insufficient. In Therapeutic Strategies in Schizophrenia (eds Mortimer, AM, McKenna, PJ) 139–56. Clinical Publishing.
Mortimer, AM (2011) The magic shotgun: does it fit the clinician, and will it point at schizophrenia? In Schizophrenia Spectrum Disorders: Advances and New Directions (vol. 3) (ed Ritsner, M) Springer.
Mortimer, AM, Spence, S (2001) Managing Negative Symptoms of Schizophrenia. Science Press.
Nielsen, J, Dahm, M, Lublin, H
et al (2010) Psychiatrists' attitude towards and knowledge of clozapine treatment. Journal of Psychopharmacology
Rudge, T, Morse, K (2001) Re-awakenings? A discourse analysis of the recovery from schizophrenia after medication change. Australian and New Zealand Journal of Mental Health Nursing
Taylor, D, Paton, C, Kapur, S (2009) The Maudsley Prescribing Guidelines (10th edn). Informa Healthcare.
Weiden, P, Aquila, R, Standard, J (1996) Atypical antipsychotic drugs and long-term outcome in schizophrenia. Journal of Clinical Psychiatry
57 (suppl 11): 53–60.
Wheeler, A, Humberstone, V, Robinson, G (2009) Outcomes for schizophrenia patients with clozapine treatment: how good does it get?
Journal of Psychopharmacology
Yamin, S, Vaddadi, K (2010) Are we using excessive neuroleptics? An argument for systematic dose reduction in stable patients with schizophrenia with specific reference to clozapine. International Review of Psychiatry
Zink, M (2005) Augmentation of olanzapine in treatment resistant schizophrenia. Journal of Psychiatry and Neuroscience